Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1282, 2009-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The US FDA `Black Box' Warning for Topical Calcineurin Inhibitors: An Ongoing Controversy
Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. :
Rosiglitazone: FDA must provide more than black box warning
Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. :
Risk Management Policy and Black-Box Warnings: A Qualitative Analysis of US FDA Proceedings
Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. :
LABA step-off in asthma patients: black-box warning may need reevaluation
Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. :